NCT00234234View on ClinicalTrials.gov

Predictors of the Response to Adalimumab in Rheumatoid Arthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Adalimumab

Trial Locations (1)

14

MARCELLI, Caen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT00234234 - Predictors of the Response to Adalimumab in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter